JUNE HANCOCK MESOTHELIOMA RESEARCH FUND
The Fund was created in 1997 to raise awareness of mesothelioma, fund research, support patients and carers and, more recently, to campaign for the Mesothelioma Charter.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves stood at £319,351, which is well above the stated policy minimum of £10,000. The charity reported a net income increase of £40,684 for the year, driven by donations and investment income, while expenditure on charitable activities remained low at £7,761. The trustees confirm there are no material uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“It is the policy of the charity to maintain unrestricted funds, which are the free reserves of the charity, the minimum level of reserves is £10,000.” — page 7
Trustees
- KIMBERLEY STUBBSchair
- ADRIAN PATRICK BOYCE BUDGEN
- Dr KATE HILL PHD, MSC
- MR DAN SMALL BA, FCA
- RUSSELL HANCOCK
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £47k | £6k |
| 30/06/2024 | £54k | £3k |
| 30/06/2023 | £46k | £604k |
| 30/06/2022 | £94k | £57k |
| 30/06/2021 | £53k | £2k |
Common questions
Is JUNE HANCOCK MESOTHELIOMA RESEARCH FUND financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves stood at £319,351, which is well above the stated policy minimum of £10,000. The charity reported a net income increase of £40,684 for the year, driven by donations and investment income, while expenditure on charitable activities remained low at £7,761. The trustees confirm there are no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were independently examined.